{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:04Z","timestamp":1793723764955,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":725,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.fertnstert.2020.01.033","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T02:44:53Z","timestamp":1587523493000},"page":"1251-1260.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency"],"prefix":"10.1016","volume":"113","author":[{"given":"Kutluk H.","family":"Oktay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Bedoschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari B.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"Taylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiny","family":"Titus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Palomaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Cigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura N.","family":"Dickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.01.033_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","article-title":"Beyond BRCA: new hereditary breast cancer susceptibility genes","volume":"41","author":"Economopoulou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib3","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","article-title":"BRCA1 germline mutations may be associated with reduced ovarian reserve","volume":"102","author":"Wang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/humrep\/dew044","article-title":"Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations","volume":"31","author":"Phillips","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/jayao.2016.0009","article-title":"Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast\/ovarian cancer risk","volume":"5","author":"Giordano","year":"2016","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib8","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/jc.2017-00765","article-title":"Ovarian aging in women with BRCA germline mutations","volume":"102","author":"Lin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1095\/biolreprod.115.132290","article-title":"BRCA mutations, DNA repair deficiency, and ovarian aging","volume":"93","author":"Oktay","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1600-0412.2012.01471.x","article-title":"The role of anti-Mullerian hormone in female fertility and infertility\u2014an overview","volume":"91","author":"Grynnerup","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","article-title":"Human ovarian follicular development: from activation of resting follicles to preovulatory maturation","volume":"71","author":"Gougeon","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib14","doi-asserted-by":"crossref","first-page":"E845","DOI":"10.1210\/jc.2015-1298","article-title":"The relationship between variation in size of the primordial follicle pool and age at natural menopause","volume":"100","author":"Depmann","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-4320(03)00088-5","article-title":"The early stages of follicular development: activation of primordial follicles and growth of preantral follicles","volume":"78","author":"Fortune","year":"2003","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1095\/biolreprod.113.117077","article-title":"The ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?","volume":"90","author":"Monniaux","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib17","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/humrep\/14.12.3077","article-title":"Birth following vitrification of a small number of human oocytes: case report","volume":"14","author":"Kuleshova","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib19","doi-asserted-by":"crossref","first-page":"pkz008","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.27952","article-title":"Comparison of age at natural menopause in BRCA1\/2 mutation carriers with a non-clinic-based sample of women in northern California","volume":"119","author":"Lin","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","article-title":"Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation","volume":"99","author":"Finch","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-006-9220-1","article-title":"Premature menopause in patients with BRCA1 gene mutation","volume":"100","author":"Rzepka-Gorska","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib23","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1634\/theoncologist.2012-0236","article-title":"Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer","volume":"17","author":"Rodriguez-Wallberg","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib26","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJM200006223422516","article-title":"Ovarian function after transplantation of frozen, banked autologous ovarian tissue","volume":"342","author":"Oktay","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/13697137.2015.1036853","article-title":"The utility of measuring anti-Mullerian hormone in predicting menopause","volume":"18","author":"Aydogan","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib29","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2010-2582","article-title":"Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer","volume":"96","author":"Anderson","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-Mullerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib32","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ejca.2014.06.011","article-title":"A highly-sensitive anti-Mullerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer","volume":"50","author":"Chai","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2020.01.033_bib33","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2005.05.3694","article-title":"Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220300364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220300364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:26:01Z","timestamp":1758011161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220300364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0015028220300364"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.01.033","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}